These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 30283002)

  • 21. Current understanding of the neurobiology of opioid use disorder: An overview.
    Moningka H; Lichenstein S; Yip SW
    Curr Behav Neurosci Rep; 2019 Mar; 6(1):1-11. PubMed ID: 34485022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Removal of prior authorization for medication-assisted treatment: impact on opioid use and policy implications in a Medicare Advantage population.
    Ferries E; Racsa P; Bizzell B; Rhodes C; Suehs B
    J Manag Care Spec Pharm; 2021 May; 27(5):596-606. PubMed ID: 33908274
    [No Abstract]   [Full Text] [Related]  

  • 23. The unique nature of public stigma toward non-medical prescription opioid use and dependence: a national study.
    Perry BL; Pescosolido BA; Krendl AC
    Addiction; 2020 Dec; 115(12):2317-2326. PubMed ID: 32219910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Problematizing the DSM-5 criteria for opioid use disorder: A qualitative analysis.
    Boyd S; Ivsins A; Murray D
    Int J Drug Policy; 2020 Apr; 78():102690. PubMed ID: 32278265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional neuroanatomy of craving in heroin use disorder: voxel-based meta-analysis of functional magnetic resonance imaging (fMRI) drug cue reactivity studies.
    Pollard AA; Hauson AO; Lackey NS; Zhang E; Khayat S; Carson B; Fortea L; Radua J; Grant I
    Am J Drug Alcohol Abuse; 2023 Jul; 49(4):418-430. PubMed ID: 36880845
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuroimaging of opioid exposure: a review of preclinical animal models to inform addiction research.
    Kamens HM; Cramer S; Hanley RN; Chase S; Wickenheisser A; Horton WJ; Zhang N
    Psychopharmacology (Berl); 2023 Dec; 240(12):2459-2482. PubMed ID: 37857897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic and epigenetic studies of opioid abuse disorder - the potential for future diagnostics.
    Abdulmalek S; Hardiman G
    Expert Rev Mol Diagn; 2023 May; 23(5):361-373. PubMed ID: 37078260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT.
    Strang J; Kelleher M; Mayet S; Day E; Hellier J; Byford S; Murphy C; McLennan B; Shearer J; Ryan E; Marsden J
    Health Technol Assess; 2019 Jan; 23(3):1-72. PubMed ID: 30702059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid Use Disorder Treatments: An Evidence Map.
    Sugarman A; Vittitow A; Cheng A; Malone M; McDonald R; Pace N; Williams O; Tofighi B; McNeely J; Schatz D; Roberts T; Hey SP; Garrity K; Lindquist K; Lee JD
    Drug Alcohol Depend; 2022 Dec; 241():109657. PubMed ID: 36332588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological treatment of pain among persons with opioid addiction: A systematic review and meta-analysis with implications for drug development.
    De Aquino JP; Flores JM; Avila-Quintero VJ; Compton P; Sofuoglu M
    Addict Biol; 2021 Jul; 26(4):e12964. PubMed ID: 32974993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How Motivations for Using Buprenorphine Products Differ From Using Opioid Analgesics: Evidence from an Observational Study of Internet Discussions Among Recreational Users.
    Butler SF; Oyedele NK; Dailey Govoni T; Green JL
    JMIR Public Health Surveill; 2020 Mar; 6(1):e16038. PubMed ID: 32209533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attentional bias in opioid users: A systematic review and meta-analysis.
    MacLean RR; Sofuoglu M; Brede E; Robinson C; Waters AJ
    Drug Alcohol Depend; 2018 Oct; 191():270-278. PubMed ID: 30157467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive brain stimulation modalities for the treatment and prevention of opioid use disorder: a systematic review of the literature.
    Young JR; Smani SA; Mischel NA; Kritzer MD; Appelbaum LG; Patkar AA
    J Addict Dis; 2020; 38(2):186-199. PubMed ID: 32469286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medications for management of opioid use disorder.
    Koehl JL; Zimmerman DE; Bridgeman PJ
    Am J Health Syst Pharm; 2019 Jul; 76(15):1097-1103. PubMed ID: 31361869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment utilization among persons with opioid use disorder in the United States.
    Wu LT; Zhu H; Swartz MS
    Drug Alcohol Depend; 2016 Dec; 169():117-127. PubMed ID: 27810654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multivariate pattern analysis links drug use severity to distributed cortical hypoactivity during emotional inhibitory control in opioid use disorder.
    Shi Z; Langleben DD; O'Brien CP; Childress AR; Wiers CE
    Neuroimage Clin; 2021; 32():102806. PubMed ID: 34525436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention and Treatment of Opioid Misuse and Addiction: A Review.
    Volkow ND; Jones EB; Einstein EB; Wargo EM
    JAMA Psychiatry; 2019 Feb; 76(2):208-216. PubMed ID: 30516809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosocial intervention utilization and substance abuse treatment outcomes in a multisite sample of individuals who use opioids.
    Harvey LM; Fan W; Cano MÁ; Vaughan EL; Arbona C; Essa S; Sanchez H; de Dios MA
    J Subst Abuse Treat; 2020 May; 112():68-75. PubMed ID: 32199548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of medication-assisted treatment for opioid use disorder.
    Ghanem N; Dromgoole D; Hussein A; Jermyn RT
    J Osteopath Med; 2022 Mar; 122(7):367-374. PubMed ID: 35285220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.